More than 80 pharmaceutical companies have called on governments to develop new ways of paying them to develop antibiotics. With drug-resistant microbes predicted to kill 10 million people a year by 2050 and cost $100 trillion in lost economic output, Redx Pharm chief executive said “there is a doomsday clock ticking, with the effectiveness of antibiotics diminishing at an alarming rate, new ways must be found to support innovation and drug discovery in this critical area”.

Knee replacement in folks over 80: Less risky than you think

Knee replacement in folks over 80: Less risky...

Johns Hopkins study shows drones can safely transport large bags of blood

Researchers from Baltimore-based Johns Hopkins...

Nuestro reloj biológico juega un papel crucial en la curación de la cirugía.

Según un estudio compartido por ScienceDaily,...

Don’t let the term ‘elective’ fool you, physicians urge the public

According to Becker’s Hospital Review, the...

Beautyberry leaf extract restores drug’s power to fight ‘superbug’

According to an article recently shared by...

Hospital acquired drug resistant infections, deaths rose 15% from 2019-20: CDC

Hospital-acquired drug-resistant infections,...

Distribuidor exclusivo.

0